TY - JOUR
T1 - The effect of cytokines on human neutrophil Fc receptor-mediated phagocytosis
AU - Capsoni, F.
AU - Bonara, P.
AU - Minonzio, F.
AU - Ongari, A. M.
AU - Colombo, G.
AU - Rizzardi, G. P.
AU - Zanussi, C.
PY - 1991
Y1 - 1991
N2 - The recombinant (r) cytokines interferon-γ (rIFN-γ), granulocyte/macrophage-colony stimulating factor (rGM-CSF) and tumor necrosis factor-α (rTNF-α) all activate neutrophils. The aim of this work was to determine the effect of these cytokines on neutrophil Fc-receptor (FcR)-mediated phagocytosis and membrane expression of FcR, particularly FcRII and FcRIII. A short treatment (≥ 15 min) of neutrophils with rGM-CSF and rTNF-α at concentrations ≥ 62.5 U/ml significantly increased their ability to bind and phagocytize IgG-coated erythrocytes (EA). Both cytokines also showed more enhancing activity when suboptimally sensitized EA were used for binding and ingestion assays. A similar treatment of neutrophils with rIFN-γ at doses up to 500 U/ml was ineffective. The effect of rGM-CSF and rTNF-α was blocked by a monoclonal anti-GM-CSF antibody and by a polyclonal anti-TNF-α antibody respectively, thus establishing that the cytokines were responsible for the activity of the recombinant preparations. The cytokine-induced enhancement of FcR-mediated phagocytosis did not correlate with an enhancement of FcRII membrane expression on treated neutrophils; rGM-CSF significantly increased FcRIII expression, but rTNF-α and rIFN-γ were both ineffective in this respect. Since different roles of FcRII and FcRIII have been reported on ligand binding and ingestion, we also studied the effect of rGM-CSF and rTNF-α on the functional properties of these FcR, using specific monoclonal antibodies (mAbs). In the blocking experiments the pretreatment of neutrophils with rGM-CSF and rTNF-α did not modify the blocking properties of either anti-FcRII or anti-FcRIII mAbs, suggesting that cytokine-pretreatment does not affect the individual contribution of each type of FcR to ligand binding and internalization. Our data point to a new activity for both rGM-CSF and rTNF-α in augmenting FcR-mediated phagocytosis on neutrophils, but the mechanism of this enhancement remains to be elucidated.
AB - The recombinant (r) cytokines interferon-γ (rIFN-γ), granulocyte/macrophage-colony stimulating factor (rGM-CSF) and tumor necrosis factor-α (rTNF-α) all activate neutrophils. The aim of this work was to determine the effect of these cytokines on neutrophil Fc-receptor (FcR)-mediated phagocytosis and membrane expression of FcR, particularly FcRII and FcRIII. A short treatment (≥ 15 min) of neutrophils with rGM-CSF and rTNF-α at concentrations ≥ 62.5 U/ml significantly increased their ability to bind and phagocytize IgG-coated erythrocytes (EA). Both cytokines also showed more enhancing activity when suboptimally sensitized EA were used for binding and ingestion assays. A similar treatment of neutrophils with rIFN-γ at doses up to 500 U/ml was ineffective. The effect of rGM-CSF and rTNF-α was blocked by a monoclonal anti-GM-CSF antibody and by a polyclonal anti-TNF-α antibody respectively, thus establishing that the cytokines were responsible for the activity of the recombinant preparations. The cytokine-induced enhancement of FcR-mediated phagocytosis did not correlate with an enhancement of FcRII membrane expression on treated neutrophils; rGM-CSF significantly increased FcRIII expression, but rTNF-α and rIFN-γ were both ineffective in this respect. Since different roles of FcRII and FcRIII have been reported on ligand binding and ingestion, we also studied the effect of rGM-CSF and rTNF-α on the functional properties of these FcR, using specific monoclonal antibodies (mAbs). In the blocking experiments the pretreatment of neutrophils with rGM-CSF and rTNF-α did not modify the blocking properties of either anti-FcRII or anti-FcRIII mAbs, suggesting that cytokine-pretreatment does not affect the individual contribution of each type of FcR to ligand binding and internalization. Our data point to a new activity for both rGM-CSF and rTNF-α in augmenting FcR-mediated phagocytosis on neutrophils, but the mechanism of this enhancement remains to be elucidated.
UR - http://www.scopus.com/inward/record.url?scp=0026391688&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026391688&partnerID=8YFLogxK
M3 - Article
C2 - 1667943
AN - SCOPUS:0026391688
SN - 0141-2760
VL - 34
SP - 115
EP - 124
JO - Journal of Clinical and Laboratory Immunology
JF - Journal of Clinical and Laboratory Immunology
IS - 3
ER -